Bacterial proteinases as targets for the development of second-generation antibiotics

Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology

Volumn 1477, Issue 1-2, 2000, Pages 35-50

  Travis, James ^a   Potempa, Jan ^a,b  

^a University of Georgia ^*  (United States)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Bacterial pathogen; Pathogenicity; Proteinase inhibitor; Proteolytic enzyme

Indexed keywords

CELL SURFACE RECEPTOR; PROTEINASE; PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR;

ANTIBACTERIAL ACTIVITY; DRUG TARGETING; NONHUMAN; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIA; DRUG DESIGN; DRUG RESISTANCE, MICROBIAL; ENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PROTEASE INHIBITORS;

BACTERIA (MICROORGANISMS); PORPHYROMONAS GINGIVALIS;

EID: 0034615573     PISSN: 01674838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4838(99)00278-2     Document Type: Review

References (145)

1. Korant B.D., Rizzo C.J. The HIV protease and therapies for AIDS. Adv. Exp. Med. Biol. 421:1997;279-284.
2. Flexner C. HIV-protease inhibitors. N. Engl. J. Med. 338:1998;1281-1292.
3. Payne J.W. Peptides and micro-organisms. Adv. Microb. Physiol. 13:1976;55-113.
4. Travis J., Potempa J., Maeda H. Are bacterial proteinases pathogenic factors? Trends Microbiol. 3:1995;405-407.
5. Maeda H., Yamamoto T. Pathogenic mechanisms induced by microbial proteases in microbial infections. Biol. Chem. Hoppe Seyler. 377:1996;217-226.
6. Maeda H. Role of microbial proteases in pathogenesis. Microbiol. Immunol. 40:1996;685-699.
7. J. Potempa and J. Travis, Proteinases as virulence factors in bacterial diseases and as potential targets for therapeutic intervention with proteinase inhibitors, in: K. von der Helm and B.D. Korant (Eds.), Proteinases as Virulence Factors in Bacterial Diseases and as Potential Targets for Therapeutic Intervention with Proteinase Inhibitors, Handbook of Experimental Pharmacology: Proteases as Targets for Chemotherapy, Springer-Verlag, Berlin, 1999, pp. 159-188.
8. Borth W. Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J. 15:1992;3345-3353.
9. Travis J., Salvesen G.S. Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52:1983;655-709.
10. Lamont R.J., Jenkinson H.F. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol. Mol. Biol. Rev. 62:1998;1244-1263.
11. Potempa J., Pavloff N., Travis J. Porphyromonas gingivalis: a proteinase/gene accounting audit. Trends Microbiol. 3:1995;430-434.
12. Potempa J., Travis J. Porphyromonas gingivalis proteinases in periodontitis, a review. Acta Biochim. Pol. 43:1996;455-465.
13. Potempa J., Korzus E., Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 269:1994;15957-15960.
14. Chang W.S., Wardell M.R., Lomas D.A., Carrell R.W. Probing serpin reactive-loop conformations by proteolytic cleavage. Biochem. J. 314:1996;647-653.
15. 1-proteinase inhibitor by Crotalus adamanteus proteinase II. J. Biol. Chem. 254:1979;5317-5320.
16. Pei D., Majmudar G., Weiss S.J. Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J. Biol. Chem. 269:1994;25849-25855.
17. Desrochers P.E., Jeffrey J.J., Weiss S.J. Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity. J. Clin. Invest. 87:1991;2258-2265.
18. 1-anti-chymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromelysin). J. Biol. Chem. 266:1991;15810-15816.
19. 1-proteinase inhibitor by human PMN leucocyte collagenase. FEBS Lett. 263:1990;355-357.
20. 1-antitrypsin by metalloproteinases released from neutrophils. J. Clin. Invest. 82:1988;706-711.
21. 1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases. J. Biol. Chem. 267:1992;5005-5012.
22. 1-proteinase inhibitor by proteinases from Staphylococcus aureus. J. Biol. Chem. 261:1986;14330-14334.
23. 1-proteinase inhibitor. J. Biol. Chem. 274:1999;12245-12251.
24. 1-antitrypsin by specific reactive centre loop cleavage: a mechanism that promotes airway inflammation and asthma. Biochem. Biophys. Res. Commun. 221:1996;59-61.
25. 1-proteinase inhibitor by cleavage in the reactive site region. J. Biol. Chem. 261:1986;14748-14751.
26. 1-proteinase inhibitor by matrilysin and stromelysin. Biochim. Biophys. Acta. 1199:1994;224-228.
27. 1-antitrypsin by human stromelysin. FEBS Lett. 279:1991;91-94.
28. 1-proteinase inhibitor by a metalloproteinase from Serratia marcescens. Biochim. Biophys. Acta. 704:1982;267-271.
29. Bagarozzi D.A. Jr., Pike R., Potempa J., Travis J. Purification and characterization of a novel endopeptidase in ragweed (Ambrosia artemisiifolia) pollen. J. Biol. Chem. 271:1996;26227-26232.
30. 2-macroglobulin with the fungal enzyme, seaprose. Biol. Chem. Hoppe Seyler. 375:1994;335-341.
31. Kress L.F., Catanese J. Enzymatic inactivation of human antithrombin III. Limited proteolysis of the inhibitor by snake venom proteinases in the presence of heparin. Biochim. Biophys. Acta. 615:1980;178-186.
32. 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis. Nature. 317:1985;730-732.
33. Carrell R.W., Evans D.L., Stein P.E. Mobile reactive centre of serpins and the control of thrombosis. Nature. 352:1991;576-578.
34. Pemberton P.A., Harrison R.A., Lachmann P.J., Carrell R.W. The structural basis for neutrophil inactivation of C1 inhibitor. Biochem. J. 258:1989;193-198.
35. Knauper V., Triebel S., Reinke H., Tschesche H. Inactivation of human plasma C1-inhibitor by human PMN leucocyte matrix metalloproteinases. FEBS Lett. 290:1991;99-102.
36. Pratt C.W., Tobin R.B., Church F.C. Interaction of heparin cofactor II with neutrophil elastase and cathepsin G. J. Biol. Chem. 265:1990;6092-6097.
37. 2-antiplasmin, angiotensinogen, and ovalbumin. Biochemistry. 30:1991;1723-1730.
38. 1-anti-chymotrypsin. Sites of cleavage and generation of chemotactic activity. J. Biol. Chem. 266:1991;21482-21487.
39. 1-anti-chymotrypsin. Biochem. J. 306:1995;191-197.
40. Potempa J., Mikolajczyk-Pawlinska J., Brassell D., Nelson D., Thogersen I.B., Enghild J.J., Travis J. Comparative properties of two cysteine proteinases (gingipains R), the products of two related but individual genes of Porphyromonas gingivalis. J. Biol. Chem. 273:1998;21648-21657.
41. Travis J., Pike R., Imamura T., Potempa J. The role of proteolytic enzymes in the development of pulmonary emphysema and periodontal disease. Am. J. Respir. Crit. Care Med. 150:1994;S143-S146.
42. Okamoto T., Akaike T., Suga M., Tanase S., Horie H., Miyajima S., Ando M., Ichinose Y., Maeda H. Activation of human matrix metalloproteinases by various bacterial proteinases. J. Biol. Chem. 272:1997;6059-6066.
43. Maeda H., Okamoto T., Akaike T. Human matrix metalloprotease activation by insults of bacterial infection involving proteases and free radicals. Biol. Chem. 379:1998;193-200.
44. Sorsa T., Ingman T., Suomalainen K., Haapasalo M., Konttinen Y.T., Lindy O., Saari H., Uitto V.I. Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases. Infect. Immun. 60:1992;4491-4495.
45. DeCarlo A.A. Jr., Windsor L.J., Bodden M.K., Harber G.J., Birkedal-Hansen B., Birkedal-Hansen H. Activation and novel processing of matrix metalloproteinases by a thiol-proteinase from the oral anaerobe Porphyromonas gingivalis. J. Dent. Res. 76:1997;1260-1270.
46. Boyle M.D., Lottenberg R. Plasminogen activation by invasive human pathogens. Thromb. Haemost. 77:1997;1-10.
47. Lottenberg R., Minning-Wenz D., Boyle M.D. Capturing host plasmin(ogen): a common mechanism for invasive pathogens? Trends Microbiol. 2:1994;20-24.
48. Coleman J.L., Roemer E.J., Benach J.L. Plasmin-coated Borrelia burgdorferi degrades soluble and insoluble components of the mammalian extracellular matrix. Infect. Immun. 67:1999;3929-3936.
49. Schenkein H.A., Berry C.R. Production of chemotactic factors for neutrophils following the interaction of Bacteroides gingivalis with purified C5. J. Periodontal Res. 23:1988;308-312.
50. Schenkein H.A. The effect of periodontal proteolytic Bacteroides species on proteins of the human complement system. J. Periodontal Res. 23:1988;187-192.
51. Schenkein H.A. The role of complement in periodontal diseases. Crit. Rev. Oral Biol. Med. 2:1991;65-81.
52. Wingrove J.A., DiScipio R.G., Chen Z., Potempa J., Travis J., Hugli T.E. Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J. Biol. Chem. 267:1992;18902-18907.
53. Harris E.D. Jr., Krane S.M. Collagenases (first of three parts). N. Engl. J. Med. 291:1974;557-563.
54. Nordwig A. Collagenolytic enzymes. Adv. Enzymol. Relat. Areas Mol. Biol. 34:1971;155-205.
55. Hase C.C., Finkelstein R.A. Bacterial extracellular zinc-containing metalloproteases. Microbiol. Rev. 57:1993;823-837.
56. Kilian M., Mestecky J., Russell M.W. Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol. Rev. 52:1988;296-303.
57. Gronbaek-Frandsen E.V. Bacterial degradation of immunoglobulin A1 in relation to periodontal diseases. APMIS. 87:1999;1-54.
58. Plaut A.G. The IgA1 proteases of pathogenic bacteria. Annu. Rev. Microbiol. 37:1983;603-622.
59. Kilian M., Reinholdt J., Lomholt H., Poulsen K., Frandsen E.V. Biological significance of IgA1 proteases in bacterial colonization and pathogenesis critical evaluation of experimental evidence. APMIS. 104:(5):1996;321-338.
60. Loomes L.M., Kerr M.A., Senior B.W. The cleavage of immunoglobulin G in vitro and in vivo by a proteinase secreted by the urinary tract pathogen Proteus mirabilis. J. Med. Microbiol. 39:1993;225-232.
61. Loomes L.M., Senior B.W., Kerr M.A. A proteolytic enzyme secreted by Proteus mirabilis degrades immunoglobulins of the immunoglobulin A1 (IgA1), IgA2, and IgG isotypes. Infect. Immun. 58:1990;1979-1985.
62. Fishburn C.S., Slaney J.M., Carman R.J., Curtis M.A. Degradation of plasma proteins by the trypsin-like enzyme of Porphyromonas gingivalis and inhibition of protease activity by a serine protease inhibitor of human plasma. Oral Microbiol. Immunol. 6:1991;209-215.
63. Holder I.A., Wheeler R. Experimental studies of the pathogenesis of infections owing to Pseudomonas aeruginosa: elastase, an IgG protease. Can. J. Microbiol. 30:1984;1118-1124.
64. Prokesova L., Potuznikova B., Potempa J., Zikan J., Radl J., Hachova L., Baran K., Porwit-Bobr Z., John C. Cleavage of human immunoglobulins by serine proteinase from Staphylococcus aureus. Immunol. Lett. 31:1992;259-265.
65. Heck L.W., Alarcon P.G., Kulhavy R.M., Morihara K., Russell M.W., Mestecky J.F. Degradation of IgA proteins by Pseudomonas aeruginosa elastase. J. Immunol. 144:1990;2253-2257.
66. Bainbridge T., Fick R.B. Jr. Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase. J. Lab. Clin. Med. 114:1989;728-733.
67. Jansen H.J., Grenier D., VanderHoeven J.S. Characterization of immunoglobulin G-degrading proteases of Prevotella intermedia and Prevotella nigrescens. Oral Microbiol. Immunol. 10:1995;138-145.
68. Wolf U., Bauer D., Traub W.H. A 41.7 kDa serine protease from Clostridium perfringens type A: degradation of purified human serum proteins. Zent.bl. Bakteriol. 277:1992;145-160.
69. Kaplan A.P., Joseph K., Shibayama Y., Reddigari S., Ghebrehiwet B., Silverberg M. The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation. Adv. Immunol. 66:1997;225-272.
70. Imamura T., Pike R.N., Potempa J., Travis J. Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J. Clin. Invest. 94:1994;361-367.
71. Kamata R., Yamamoto T., Matsumoto K., Maeda H. A serratial protease causes vascular permeability reaction by activation of the Hageman factor-dependent pathway in guinea pigs. Infect. Immun. 48:1985;747-753.
72. Molla A., Yamamoto T., Akaike T., Miyoshi S., Maeda H. Activation of Hageman factor and prekallikrein and generation of kinin by various microbial proteinases. J. Biol. Chem. 264:1989;10589-10594.
73. Sakata Y., Akaike T., Khan M.M., Ichinose Y., Hirayama H., Suga M., Ando M., Maeda H. Activation of bradykinin generating cascade by Vibrio cholerae protease. Immunopharmacology. 33:1996;377-379.
74. Maruo K., Akaike T., Inada Y., Ohkubo I., Ono T., Maeda H. Effect of microbial and mite proteases on low and high molecular weight kininogens. Generation of kinin and inactivation of thiol protease inhibitory activity. J. Biol. Chem. 268:1993;17711-17715.
75. Herwald H., Collin M., Muller-Esterl W., Bjorck L. Streptococcal cysteine proteinase releases kinins: a virulence mechanism. J. Exp. Med. 184:1996;665-673.
76. Maruo K., Akaike T., Ono T., Maeda H. Involvement of bradykinin generation in intravascular dissemination of Vibrio vulnificus and prevention of invasion by a bradykinin antagonist. Infect. Immun. 66:1998;866-969.
77. Sakata Y., Akaike T., Suga M., Ijiri S., Ando M., Maeda M. Bradykinin generation triggered by Pseudomonas proteases facilitates invasion of the systemic circulation by Pseudomonas aeruginosa. Microbiol. Immunol. 40:1996;415-423.
78. Hong Y.Q., Ghebrehiwet B. Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3. Clin. Immunol. Immunopathol. 62:1992;133-138.
79. Schultz D.R., Miller K.D. Elastase of Pseudomonas aeruginosa: inactivation of complement components and complement-derived chemotactic and phagocytic factors. Infect. Immun. 10:1974;128-135.
80. Sundqvist G., Carlsson J., Herrmann B., Tarnvik A. Degradation of human immunoglobulins G and M and complement factors C3 and C5 by black-pigmented Bacteroides. J. Med. Microbiol. 19:1985;85-94.
81. Schenkein H.A. The effect of periodontal proteolytic Bacteroides species on proteins of the human complement system. J. Periodontal Res. 23:1988;187-192.
82. Cleary P.P., Prahbu U., Dale J.B., Wexler D.E., Handley J. Streptococcal C5a peptidase is a highly specific endopeptidase. Infect. Immun. 60:1992;5219-5223.
83. Oda T., Kojima Y., Akaike T., Ijiri S., Molla A., Maeda H. Inactivation of chemotactic activity of C5a by the serratial 56-kilodalton protease. Infect. Immun. 58:1990;1269.
84. Wegrzynowicz Z., Heczko P.B., Drapeau G.R., Jeljaszewicz J., Pulverer G. Prothrombin activation by a metalloprotease from Staphylococcus aureus. J. Clin. Microbiol. 12:1980;138-139.
85. Kaminishi H., Hamatake H., Cho T., Tamaki T., Suenaga N., Fujii T., Hagihara Y., Maeda H. Activation of blood clotting factors by microbial proteinases. FEMS Microbiol. Lett. 121:1994;327-332.
86. Hosotaki K., Imamura T., Potempa J., Kitamura N., Travis J. Activation of protein C by arginine-specific cysteine proteinases (gingipains-R) from Porphyromonas gingivalis. Biol. Chem. 380:1999;75-80.
87. Imamura T., Potempa J., Tanase S., Travis J. Activation of blood coagulation factor X by arginine-specific cysteine proteinases (gingipain-Rs) from Porphyromonas gingivalis. J. Biol. Chem. 272:1997;16062-16067.
88. Bordusa F., Ullmann D., Jakubke H.D. Subsite specificity studies on the unusual cysteine protease clostripain: charged residues in the P3 position indicate a narrow subsite region. Biol. Chem. 378:1997;1193-1198.
89. Meyer D.H., Fives-Taylor P.M. Oral pathogens: from dental plaque to cardiac disease. Curr. Opin. Microbiol. 1:1998;88-95.
90. Page R.C. The pathobiology of periodontal diseases may affect systemic diseases: inversion of a paradigm. Ann. Periodontol. 31:1998;108-120.
91. Haraszthy V.I., Zambon J.J., Trevisan M., Shah R., Zeid M., Genco R.J. Identification of pathogens in atheromatous plaques. J. Dent. Res. 77:1998;273.
92. Korhonen T.K., Lahteenmaki K., Kukkonen M., Pouttu R., Hynonen U., Savolainen K., Westerlund-Wikstrom B., Virkola R. Plasminogen receptors. Turning Salmonella and Escherichia coli into proteolytic organisms. Adv. Exp. Med. Biol. 412:1997;185-192.
93. Sjostrom I., Grondahl H., Falk G., Kronvall G., Ullberg M. Purification and characterisation of a plasminogen-binding protein from Haemophilus influenzae. Sequence determination reveals identity with aspartase. Biochim. Biophys. Acta. 1324:1997;182-190.
94. Ullberg M., Kronvall G., Karlsson I., Wiman B. Receptors for human plasminogen on Gram-negative bacteria. Infect. Immun. 58:1990;21-25.
95. Ringner M., Valkonen K.H., Wadstrom T. Binding of vitronectin and plasminogen to Helicobacter pylori. FEMS Immunol. Med. Microbiol. 9:1994;29-34.
96. Pantzar M., Ljungh A., Wadstrom T. Plasminogen binding and activation at the surface of Helicobacter pylori CCUG 17874. Infect. Immun. 66:1998;4976-4980.
97. Ullberg M., Kuusela P., Kristiansen B.E., Kronvall G. Binding of plasminogen to Neisseria meningitidis and Neisseria gonorrhoeae and formation of surface-associated plasmin. J. Infect. Dis. 166:1992;1329-1334.
98. Kuusela P., Saksela O. Binding and activation of plasminogen at the surface of Staphylococcus aureus. Increase in affinity after conversion to the Lys form of the ligand. Eur. J. Biochem. 193:1990;759-765.
99. Svensson M.D., Sjobring U., Bessen D.E. Selective distribution of a high-affinity plasminogen-binding site among group A streptococci associated with impetigo. Infect. Immun. 67:1999;3915-3920.
100. Eberhard T., Kronvall G., Ullberg M. Surface bound plasmin promotes migration of Streptococcus pneumoniae through reconstituted basement membranes. Microb. Pathog. 26:1999;175-181.
101. D'Costa S.S., Boyle M.D. Interaction of a group A Streptococcus within human plasma results in assembly of a surface plasminogen activator that contributes to occupancy of surface plasmin-binding structures. Microb. Pathog. 24:1998;341-349.
102. Leytus S.P., Bowles L.K., Konisky J., Mangel W.F. Activation of plasminogen to plasmin by a protease associated with the outer membrane of Escherichia coli. Proc. Natl. Acad. Sci. USA. 78:1981;1485-1485.
103. Mangel W.F., Toledo D.L., Brown M.T., Worzalla K., Lee M., Dunn J.J. Omptin: an Escherichia coli outer membrane proteinase that activates plasminogen. Methods Enzymol. 244:1994;384-399.
104. Sodeinde O.A., Subrahmanyam Y.V., Stark K., Quan T., Bao Y., Goguen J.D. A surface protease and the invasive character of plague. Science. 258:1992;1004-1007.
105. Stathopoulos C. Structural features, physiological roles, and biotechnological applications of the membrane proteases of the OmpT bacterial endopeptidase family: a micro-review. Membr. Cell Biol. 12:1998;1-8.
106. Sodeinde O.A., Goguen J.D. Nucleotide sequence of the plasminogen activator gene of Yersinia pestis: relationship to ompT of Escherichia coli and gene E of Salmonella typhimurium. Infect. Immun. 57:1989;1517-1523.
107. Lundrigan M.D., Webb R.M. Prevalence of ompT among Escherichia coli isolates of human origin. FEMS Microbiol. Lett. 76:1992;51-56.
108. Imamura T., Potempa J., Pike R.N., Moore J.N., Barton M.H., Travis J. Effect of free and vesicle-bound cysteine proteinases of Porphyromonas gingivalis on plasma clot formation: implications for bleeding tendency at periodontitis sites. Infect. Immun. 63:1995;4877-4882.
109. Pike R.N., Potempa J., McGraw W., Coetzer T.H., Travis J. Characterization of the binding activities of proteinase-adhesin complexes from Porphyromonas gingivalis. J. Bacteriol. 178:1996;2876-2882.
110. Rosen G., Naor R., Kutner S., Sela M.N. Characterization of fibrinolytic activities of Treponema denticola. Infect. Immun. 62:1994;1749-1754.
111. Matsuka Y.V., Pillai S., Gubba S., Musser J.M., Olmsted S.B. Fibrinogen cleavage by the Streptococcus pyogenes extracellular cysteine protease and generation of antibodies that inhibit enzyme proteolytic activity. Infect. Immun. 67:1999;4326-4333.
112. Fricke B., Parchmann O., Kruse K., Rucknagel P., Schierhorn A., Menge S. Characterization and purification of an outer membrane metalloproteinase from Pseudomonas aeruginosa with fibrinogenolytic activity. Biochim. Biophys. Acta. 1454:1999;236-250.
113. Shibuya Y., Yamamoto T., Morimoto T., Nishino N., Kambara T., Okabe H. Pseudomonas aeruginosa alkaline proteinase might share a biological function with plasmin. Biochim. Biophys. Acta. 1077:1991;316-324.
114. Engel L.S., Hill J.M., Caballero A.R., Green L.C., O'Callaghan R.J. Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa. J. Biol. Chem. 273:1998;16792-16797.
115. Mintz C.S., Miller R.D., Gutgsell N.S., Malek T. Legionella pneumophila protease inactivates interleukin-2 and cleaves CD4 on human T cells. Infect. Immun. 61:1993;3416-3421.
116. Horvat R.T., Parmely M.J. Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity. Infect. Immun. 56:1988;2925-2932.
117. 2-macroglobulin. Infect. Immun. 57:1989;1668-1674.
118. Parmely M., Gale A., Clabaugh M., Horvat R., Zhou W.W. Proteolytic inactivation of cytokines by Pseudomonas aeruginosa. Infect. Immun. 58:1990;3009-3014.
119. Calkins C.C., Platt K., Potempa J., Travis J. Inactivation of tumor necrosis factor-α by proteinases (gingipains) from the periodontal pathogen, Porphyromonas gingivalis. Implications of immune evasion. J. Biol. Chem. 273:1998;6611-6614.
120. Fletcher J., Nair S., Poole S., Henderson B., Wilson M. Cytokine degradation by biofilms of Porphyromonas gingivalis. Curr. Microbiol. 36:1998;216-219.
121. Fletcher J., Reddi K., Poole S., Nair S., Henderson B., Tabona P., Wilson M. Interactions between periodontopathogenic bacteria and cytokines. J. Periodontal Res. 32:1997;200-205.
122. Banbula A., Bugno M., Kuster A., Heinrich P.C., Travis J., Potempa J. Rapid and efficient inactivation of IL-6 gingipains, lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Biochem. Biophys. Res. Commun. 261:1999;598-602.
123. Yun P.L., DeCarlo A.A., Hunter N. Modulation of major histocompatibility complex protein expression by human gamma interferon mediated by cysteine proteinase-adhesin polyproteins of Porphyromonas gingivalis. Infect. Immun. 67:1999;2986-2995.
124. Mikolajczyk-Pawlinska J., Travis J., Potempa J. Modulation of interleukin-8 activity by gingipains from Porphyromonas gingivalis: implications for pathogenicity of periodontal disease. FEBS Lett. 440:1998;282-286.
125. Padrines M., Wolf M., Walz A., Baggiolini M. Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett. 352:1994;231-235.
126. Zhang J., Dong H., Kashket S., Duncan M.J. IL-8 degradation by Porphyromonas gingivalis proteases. Microb. Pathog. 26:1999;275-280.
127. Wolf B.B., Gibson C.A., Kapur V., Hussaini I.M., Musser J.M., Gonias S.L. Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface. J. Biol. Chem. 269:1994;30682.
128. Vollmer P., Walev I., Rose-John S., Bhakdi S. Novel pathogenic mechanism of microbial metalloproteinases: liberation of membrane-anchored molecules in biologically active form exemplified by studies with the human interleukin-6 receptor. Infect. Immun. 64:1996;3646-3651.
129. Lourbakos A., Chinni C., Thompson P., Potempa J., Travis J., Mackie E.J., Pike R.N. Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett. 435:1998;45-48.
130. Tonello F., Morante S., Rossetto O., Schiavo G., Montecucco C. Tetanus and botulism neurotoxins: a novel group of zinc-endopeptidases. Adv. Exp. Med. Biol. 389:1996;251-260.
131. Duesbery N.S., Webb C.P., Leppla S.H., Gordon V.M., Klimpel K.R., Copeland T.D., Ahn N.G., Oskarsson M.K., Fukasawa K., Paull K.D., Vande-Woude G.F. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science. 280:1998;734-737.
132. Tashiro M., Ciborowski P., Klenk H.D., Pulverer G., Rott R. Role of Staphylococcus protease in the development of influenza pneumonia. Nature. 325:1987;536-537.
133. Tashiro M., Ciborowski P., Reinacher M., Pulverer G., Klenk H.D., Rott R. Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. Virology. 157:1987;421-430.
134. Scheiblauer H., Reinacher M., Tashiro M., Rott R. Interactions between bacteria and influenza A virus in the development of influenza pneumonia. J. Infect. Dis. 166:1992;783-791.
135. Page R.C., Offenbacher S., Schroeder H.E., Seymour G.J., Kornman K.S. Advances in the pathogenesis of periodontitis summary of developments, clinical implications and future directions. Periodontol. 2000. 14:1997;216-248.
136. Darveau R.P., Tanner A., Page R.C. The microbial challenge in periodontitis. Periodontol. 2000. 14:1997;12-32.
137. Lamont R.J., Jenkinson H.F. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol. Mol. Biol. Rev. 62:1998;1244-1263.
138. Potempa J., Travis J. Porphyromonas gingivalis proteinases in periodontitis, a review. Acta Biochim. Pol. 43:1996;455-465.
139. Potempa J., Pavloff N., Travis J. Porphyromonas gingivalis: a proteinase/gene accounting audit. Trends Microbiol. 3:1995;430-434.
140. J. Potempa, A. Banbula and J. Travis, Role of bacterial proteinases in matrix destruction and modulation of host responses, Periodontol. 2000 (in press).
141. Kolenbrander P.E., London J. Adhere today, here tomorrow: oral bacterial adherence. J. Bacteriol. 175:1993;3247-3252.
142. Cutler C.W., Arnold R.R., Schenkein H.A. Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalis. J. Immunol. 15:1993;7016-7029.
143. Jagels M.A., Travis J., Potempa J., Pike R., Hugli T.E. Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis. Infect. Immun. 64:1996;1984-1991.
144. Lala A., Amano A., Sojar H.T., Radel S.J., DeNardin E. Porphyromonas gingivalis trypsin-like protease: a possible natural ligand for the neutrophil formyl peptide receptor. Biochem. Biophys. Res. Commun. 199:1994;1489-1496.
145. Imamura T., Potempa J., Pike R.N., Travis J. Dependence of vascular permeability enhancement on cysteine proteinases in vesicles of Porphyromonas gingivalis. Infect. Immun. 63:1995;1999-2003.